Johnson & Johnson ups expectations


With a number of acquisitions and new product approvals, Johnson & Johnson looked beyond a dip in second-quarter profit and raised its outlook for the year. The health care products giant expects sales and profit growth to accelerate this year, with momentum carrying over into 2018.



from Biotech News